MODERATOR
:
SPEAKER
(S):
Dr. Beth Shaz, MD, Chief Medical Officer, New York Blood Center
Development of a Massive Transfusion Protocol
John R. Hess, MD, Professor of Pathology and Medicine, University of Maryland Medical School
Applying lessons learned from the military to civilian hospitals
Dr. Orieji Illoh, MD, Deputy Director, Division of Blood Applications, Food and Drug Administration
Massive Transfusion protocols: Why, When and How
Description
This will be a workshop on how to develop, implement, and continue to improve massive transfusion protocols. Areas of focus will be product inventory, such as availability of thawed plasma, use of pre-pooled cryoprecipitate, and use of group O Red Blood Cells. Additionally, points of discussion will be adequate laboratory support including coagulation testing, tracking product wastage, turnaround times and other quality indicators.
-
Determine the benefits and risks of different approaches to massive transfusion protocols.
-
Discuss how the continual improvements in a massive transfusion protocol are created.
-
Explain the development of a massive transfusion protocol.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.